2023-05-01 2024-04-30 false No description of principal activity Capium Accounts Production 1.1 11963023 2023-05-01 2024-04-30 11963023 bus:FullAccounts 2023-05-01 2024-04-30 11963023 bus:FRS102 2023-05-01 2024-04-30 11963023 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 11963023 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 11963023 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 11963023 2023-05-01 2024-04-30 11963023 2024-04-30 11963023 bus:RegisteredOffice 2023-05-01 2024-04-30 11963023 core:WithinOneYear 2024-04-30 11963023 core:AfterOneYear 2024-04-30 11963023 1 2023-05-01 2024-04-30 11963023 bus:Director1 2023-05-01 2024-04-30 11963023 bus:Director1 2024-04-30 11963023 bus:Director1 2022-05-01 2023-04-30 11963023 2022-05-01 11963023 bus:LeadAgentIfApplicable 2023-05-01 2024-04-30 11963023 2022-05-01 2023-04-30 11963023 2023-04-30 11963023 core:WithinOneYear 2023-04-30 11963023 core:AfterOneYear 2023-04-30 11963023 bus:EntityAccountantsOrAuditors 2022-05-01 2023-04-30 11963023 bus:OrdinaryShareClass1 2023-05-01 2024-04-30 11963023 bus:OrdinaryShareClass1 2024-04-30 11963023 bus:OrdinaryShareClass1 2022-05-01 2023-04-30 11963023 bus:OrdinaryShareClass1 2023-04-30 11963023 core:PlantMachinery 2023-05-01 2024-04-30 11963023 core:PlantMachinery 2024-04-30 11963023 core:PlantMachinery 2023-04-30 11963023 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-04-30 11963023 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-04-30 11963023 core:CostValuation core:Non-currentFinancialInstruments 2024-04-30 11963023 core:CostValuation core:Non-currentFinancialInstruments 2023-04-30 11963023 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-04-30 11963023 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-30 11963023 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-30 11963023 core:Non-currentFinancialInstruments 2024-04-30 11963023 core:Non-currentFinancialInstruments 2023-04-30 11963023 core:ShareCapital 2024-04-30 11963023 core:ShareCapital 2023-04-30 11963023 core:RetainedEarningsAccumulatedLosses 2024-04-30 11963023 core:RetainedEarningsAccumulatedLosses 2023-04-30 11963023 dpl:Item1 2023-05-01 11963023 dpl:Item1 2024-04-30 11963023 dpl:Item1 2022-05-01 11963023 dpl:Item1 2023-04-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11963023
England and Wales

 

 

 

NG PHYSIOTHERAPY LIMITED


Unaudited Financial Statements
 


Period of accounts

Start date: 01 May 2023

End date: 30 April 2024
Director N Goringe
Registered Number 11963023
Registered Office 28 Barn Owl Way
Burghfield Common
Reading
RG7 3XX
Accountants Blue Peak
100 Berkshire Place
GF33
Winnersh
RG41 5RD
1
 
 
Notes
 
2024
£
  2023
£
Current assets      
Debtors 4 3,977    9,843 
Cash at bank and in hand 7,124    1,737 
11,101    11,580 
Creditors: amount falling due within one year 5 (7,831)   (6,194)
Net current assets 3,270    5,386 
 
Total assets less current liabilities 3,270    5,386 
Net assets 3,270    5,386 
 

Capital and reserves
     
Called up share capital 6 100    100 
Profit and loss account 3,170    5,286 
Shareholders' funds 3,270    5,386 
 


For the year ended 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 26 January 2025 and were signed by:


-------------------------------
N Goringe
Director
2
Company information
NG Physiotherapy Limited is a private company limited by shares incorporated in England and Wales. The registered office is 28 Barn Owl Way, Burghfield Common, Reading, RG7 3XX.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102(1A) The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference
arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss. Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and Machinery 3 Years Straight Line
Cash at bank and in hand
Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
2.

Average number of employees

Average number of employees during the year was 1 (2023 : 1).
3.

Tangible fixed assets

Cost or valuation Plant and Machinery   Total
  £   £
At 01 May 2023  
Additions 459    459 
Disposals  
At 30 April 2024 459    459 
Depreciation
At 01 May 2023 459    459 
Charge for year  
On disposals  
At 30 April 2024 459    459 
Net book values
Closing balance as at 30 April 2024  
Opening balance as at 01 May 2023  


4.

Debtors: amounts falling due within one year

2024
£
  2023
£
Directors' Current Accounts 3,977    9,843 
3,977    9,843 

5.

Creditors: amount falling due within one year

2024
£
  2023
£
Corporation Tax 7,831    6,194 
7,831    6,194 

6.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
100 Ordinary shares of £1.00 each 100    100 
100    100 

3